Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.89% | -92.14% | -45.48% | 96.03% | -922.93% |
| Total Depreciation and Amortization | 4.79% | -13.92% | 0.16% | -17.76% | -2.21% |
| Total Amortization of Deferred Charges | 5.73% | 17.73% | -0.65% | 16.44% | -0.38% |
| Total Other Non-Cash Items | -73.42% | 85.75% | -14.25% | -95.56% | 1,882.97% |
| Change in Net Operating Assets | 133.23% | -476.86% | -25.60% | 250.58% | 81.53% |
| Cash from Operations | 474.36% | -81.47% | -22.03% | 24.23% | 894.20% |
| Capital Expenditure | 53.48% | 55.54% | -283.97% | 16.47% | -66.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 98.93% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.22% | -137.90% | 20.44% | -14.38% | 24.81% |
| Cash from Investing | 51.57% | -315.83% | 4.83% | -12.25% | 21.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -9.49% | -62.63% | 115.05% | -75.00% | 132.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -260.87% | -122.12% |
| Cash from Financing | -71,612.74% | -62.63% | 194.84% | -81.66% | 117.30% |
| Foreign Exchange rate Adjustments | 183.03% | 141.12% | -319.28% | 702.05% | 67.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -389.27% | -292.79% | -33.16% | 26.43% | 350.38% |